title: Etomidate and propofol-hyposensitive GABAA receptor beta3(N265M) mice show little changes in acute alcohol sensitivity but enhanced tolerance and withdrawal.
abstract: Gamma-aminobutyric acid-A (GABAA) receptors are ligand-gated ion channels comprised of subunits from several classes (alpha, beta, gamma, delta). Recent studies have clearly demonstrated that the functional properties of GABAA receptors are altered following chronic ethanol administration that could provide the molecular basis for the previously proposed role of these receptors in ethanol tolerance and dependence. Because the subunit composition of GABAA receptors determines receptor pharmacology, the present study was devoted to assess if the behavioral sensitivity after acute and chronic ethanol exposure depends on beta3-containing GABAA receptors. In the present study, we used knock-in mice harboring a point mutation (N265M) in the second transmembrane region of the beta3 subunit of the GABAA receptor in order to study acute and chronic behavioral effects of ethanol. More specifically, we tested tolerance to loss of righting reflex (LORR) and the development of withdrawal signs after chronic ethanol exposure using ethanol vapor chambers. Our results show that the beta3(N265M) mutation does not play a major modulatory role of acute ethanol-induced LORR. However, following repeated LORR testing, enhanced tolerance to the intoxicating effects of ethanol was observed--a finding which was unrelated to the pharmacokinetics of ethanol as both genotypes had the same blood alcohol concentrations following repeated LORR testing. In addition, following chronic alcohol vapor exposure, mouse mutants displayed increased handling-induced convulsions during withdrawal. The results of the present study suggest that the alcohol effects abolished by the beta3(N265M) mutation do not play a dominant role in acute alcohol intoxication but influence ethanol tolerance and withdrawal.
authors.affiliation: Department of Psychopharmacology, Central Institute of Mental Health, Mannheim, Germany.
authors.forename: Carles
authors.initials: C
authors.lastname: Sanchis-Segura
authors.forename: Brandon
authors.initials: B
authors.lastname: Cline
authors.forename: Rachel
authors.initials: R
authors.lastname: Jurd
authors.forename: Uwe
authors.initials: U
authors.lastname: Rudolph
authors.forename: Rainer
authors.initials: R
authors.lastname: Spanagel
mesh_terms: D020751:Alcohol-Induced Disorders / Q000235:genetics* / Q000503:physiopathology; D000704:Analysis of Variance; D000818:Animals; D001216:Asparagine / Q000235:genetics; D004361:Drug Tolerance / Q000235:genetics*; D000431:Ethanol / Q000008:administration & dosage / Q000097:blood; D005045:Etomidate / Q000008:administration & dosage*; D006993:Hypnotics and Sedatives / Q000008:administration & dosage*; D008715:Methionine / Q000235:genetics; D051379:Mice; D008822:Mice, Transgenic; D015742:Propofol / Q000008:administration & dosage*; D011963:Receptors, GABA-A / Q000235:genetics*; D012018:Reflex / Q000187:drug effects
chemical_list: D006993:Hypnotics and Sedatives; D011963:Receptors, GABA-A; D000431:Ethanol; D001216:Asparagine; D008715:Methionine; D015742:Propofol; D005045:Etomidate